/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
The Hyderabad-based generics maker is now India’s largest supplier of off-patent medicines to the US.
On 3 June, Aurobindo Pharma Ltd announced its annual results. It had turned in a stellar performance, with an all-round improvement in sales and profits. And, on 10 August, its stock raced past Rs 950, the highest level in a decade. But one highlight went almost unnoticed.
In fiscal year 2020, the company’s US sales totted up to $1,622 million, making it the top pharmaceuticals supplier to the lucrative American market and ousting Sun Pharmaceutical Industries Ltd, which notched up $1,487 million, from the top slot.
No small achievement this, considering Aurobindo Pharma’s ascension to the top of the exporters’ …
